/PARNF

PARNF Stock - Parnell Pharmaceuticals Holdings Ltd

Q: What is the analyst price target for PARNF?

Analyst price target information is not currently available for PARNF.

Q: What is PARNF's market cap?

Market capitalization information is not currently available for PARNF.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$0.08-51.52%

$0.09 (-51.52%) • Apr 22

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.09

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for PARNF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2017

FY2018

FY2019

FY2020

FY2021

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta626.88

52W High$0.35

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2021	FY2020	FY2019	FY2018	FY2017
Revenue	$34.17M	$30.00M	$28.99M	$26.55M	$19.13M
Gross Profit	$19.26M	$17.52M	$17.39M	$15.52M	$9.38M
Gross Margin	56.4%	58.4%	60.0%	58.5%	49.0%
Operating Income	$1.35M	$3.78M	$1.36M	$2.61M	$-14,268,528
Net Income	$-1,419,593	$-15,060,717	$-7,182,161	$129,620	$-23,128,387
Net Margin	-4.2%	-50.2%	-24.8%	0.5%	-120.9%
EPS	$-0.05	$-0.81	$-0.40	$0.01	$-1.27

Company Overview

Parnell Pharmaceuticals Holdings Ltd, a commercial-stage pharmaceutical company, focuses on developing, manufacturing, and marketing animal pharmaceutical products worldwide. The company operates through four segments: Companion Animal, Production Animal - U.S., Production Animal - Rest of World, and Manufacturing Operations. It markets various products, including estroPLAN and GONAbreed reproductive hormone products for enhancing cattle breeding performance; Zydax for the treatment of osteoarthritis (OA) in dogs and horses; and Glyde, a nutraceutical product for the treatment of OA, as well as Parnell PROcept, which adds an additional injection of estroPLAN after the first injection. The company also offers mySYNCH, a digital tool to help veterinarians and producers optimize reproduction and maximize economic gains. Parnell Pharmaceuticals Holdings Ltd was incorporated in 2009 and is headquartered in Alexandria, Australia.

Visit Website

Earnings History & Surprises

PARNF

Beat Rate

60%

Last 5 quarters

Avg Surprise

-0.4%

EPS vs Estimate

Beats / Misses

3/2

Last 12 quarters

Latest EPS

$-0.12

Q1 2017

EPS Surprise History

Q4 13

No data

Q4 14

No data

Q3 15

+15.4%

$-0.22vs$-0.26

Q4 15

+18.2%

$-0.18vs$-0.22

Q1 16

+29.5%

$-0.62vs$-0.88

Q3 16

-14.9%

$-0.85vs$-0.74

Q4 16

No data

Q1 17

-50.0%

$-0.12vs$-0.08

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q4 2024	Nov 28, 2024	—	—	—	—
Q2 2020	Apr 3, 2020	—	—	—	—
Q1 2017	Mar 21, 2017	$-0.08	$-0.12	-50.0%	✗ MISS
Q4 2016	Nov 2, 2016	—	$-0.25	—	—
Q3 2016	Aug 4, 2016	$-0.74	$-0.85	-14.9%	✗ MISS
Q2 2016	Jun 1, 2016	—	—	—	—
Q1 2016	Feb 24, 2016	$-0.88	$-0.62	+29.5%	✓ BEAT
Q4 2015	Oct 21, 2015	$-0.22	$-0.18	+18.2%	✓ BEAT
Q3 2015	Aug 11, 2015	$-0.26	$-0.22	+15.4%	✓ BEAT
Q2 2015	Apr 22, 2015	$-0.19	—	—	—
Q1 2015	Feb 25, 2015	$-0.11	—	—	—
Q4 2014	Dec 31, 2014	—	$-0.50	—	—
Q4 2013	Dec 31, 2013	—	$-0.11	—	—

Frequently Asked Questions about PARNF

What is PARNF's current stock price?

Parnell Pharmaceuticals Holdings Ltd (PARNF) is currently trading at $0.08 per share. The stock has moved -51.52% today.

What is the analyst price target for PARNF?

No analyst price targets are currently available for this stock.

What sector is Parnell Pharmaceuticals Holdings Ltd in?

Parnell Pharmaceuticals Holdings Ltd operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is PARNF's market cap?

Parnell Pharmaceuticals Holdings Ltd has a market capitalization of $0.00 billion, making it a small-cap company.

Does PARNF pay dividends?

No, Parnell Pharmaceuticals Holdings Ltd does not currently pay a dividend to shareholders.